Nanobiosensor

Nanobiosensors are devices developed by integrating biological recognition elements with nanoscale sensing systems, offering high specificity and sensitivity in disease diagnosis. The enhancement of traditional biosensor technologies with nanomaterials has enabled the detection of biomarkers at extremely low concentrations and improved diagnostic accuracy by 20–30% in early detection. Nanobiosensors are widely used for the rapid, accurate, and non-invasive diagnosis of numerous health conditions including cancer, diabetes, infectious diseases, and neurodegenerative disorders.

Structure and Working Principle

A nanobiosensor consists of a biological recognition element (enzyme, antibody, DNA, aptamer, etc.), a transducer (signal converter), and a signal processing module. The biochemical change resulting from the interaction with the target molecule is converted into a measurable electrical, optical, or mechanical signal.

Contribution of Nanomaterials

Nanotechnology enables signal amplification, shorter response times, increased binding sites, and lower detection limits through nanostructures used on the sensing surface of biosensors. Commonly used nanomaterials and their properties include:

• Gold nanoparticles (AuNPs): Used in colorimetric diagnostics due to their optical properties. For example, AuNP-based sensors achieve sensitivity down to 0.1 pg/mL in the detection of prostate-specific antigen (PSA).
• Carbon nanotubes (CNTs): Increase the signal in electrochemical sensors by 40–70% due to their high surface area and electrical conductivity.
• Graphene: Provides 50–100% signal amplification and achieves lower detection limits owing to its ultrathin structure.
• Quantum dots: Deliver strong signal generation and photostability in fluorescence-based systems.

Applications in Diagnosis

Cancer Diagnosis

Nanobiosensors can detect specific proteins in blood (PSA, HER2, CEA) or DNA/RNA sequences with nanometric sensitivity. For instance, electrochemical sensors functionalized with AuNPs offer a detection limit of 0.1 pg/mL and 85–90% sensitivity for prostate cancer. The rate of early diagnosis has increased by 20% with the use of nanobiosensors.

Infectious Diseases

The genetic material or surface proteins of viruses and bacteria are directly detected by nanobiosensors. For diseases such as COVID-19 and HIV, detection times range from 5 to 10 minutes, with false-positive rates at 1–2%. These rapid and portable diagnostic systems play a critical role in field and emergency settings.

Neurodegenerative Diseases

The detection of proteins such as beta-amyloid (in the range of 10–100 pg/mL) and alpha-synuclein in Alzheimer’s and Parkinson’s diseases is made possible through sensors functionalized with nanostructures. This enables early diagnosis and monitoring of disease progression.

Monitoring Cardiovascular Biomarkers

The rise in cardiac troponin levels prior to a heart attack can be detected by nanobiosensors within 3–5 minutes. Clinical accuracy ranges from 95–98%, making these devices life-saving in emergency interventions.

Signal Transduction Techniques

• Electrochemical Sensors: Measure electrical changes resulting from target molecule interactions. Their low cost and portability make them widely used.
• Optical Sensors: Rely on changes in plasmon resonance, fluorescence, and absorbance. Supported by gold nanoparticles and quantum dots.
• Piezoelectric and Mechanical Sensors: Highly sensitive to mass changes; antigen-antibody binding alters resonance frequency.

Portable Diagnostic Systems and Point-of-Care (PoC) Applications

Nanobiosensors have been integrated with microfluidic systems to create portable devices usable at home and in the field. These systems:

• Operate with a single drop of blood or saliva,
• Deliver results within 5–15 minutes,
• Can be integrated with smartphones,
• Have a device cost ranging from $50 to $200,
• Are used in 10–20% of cases in developing countries.

These features democratize access to healthcare and provide opportunities for early diagnosis, particularly in rural areas.